Brown Advisory’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,338
| Closed | -$63.4K | – | 1275 |
|
|
2024
Q2 | $63.4K | Hold |
19,338
| – | – | ﹤0.01% | 1208 |
|
|
2024
Q1 | $142K | Sell |
19,338
-26
| -0.1% | -$191 | ﹤0.01% | 1198 |
|
|
2023
Q4 | $72.4K | Hold |
19,364
| – | – | ﹤0.01% | 1195 |
|
|
2023
Q3 | $41.1K | Buy |
19,364
+6,735
| +53% | +$14.3K | ﹤0.01% | 1173 |
|
|
2023
Q2 | $60.1K | Buy |
+12,629
| New | +$60.1K | ﹤0.01% | 1160 |
|
|
2023
Q1 | – | Sell |
-10,949
| Closed | -$110K | – | 1225 |
|
|
2022
Q4 | $110K | Sell |
10,949
-508,942
| -98% | -$5.14M | ﹤0.01% | 1164 |
|
|
2022
Q3 | $11.7M | Buy |
519,891
+4,859
| +0.9% | +$109K | 0.02% | 360 |
|
|
2022
Q2 | $12.8M | Buy |
515,032
+11,635
| +2% | +$288K | 0.02% | 349 |
|
|
2022
Q1 | $19.5M | Buy |
503,397
+236,931
| +89% | +$9.19M | 0.03% | 323 |
|
|
2021
Q4 | $15.6M | Buy |
+266,466
| New | +$15.6M | 0.02% | 355 |
|